2022
DOI: 10.1016/j.bjps.2021.05.056
|View full text |Cite
|
Sign up to set email alerts
|

Hand surgery in recessive dystrophic epidermolysis bullosa: Our experience with dermal substitutes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 17 publications
0
5
0
Order By: Relevance
“…The use of genetically corrected autologous tissue engineered grafts looks even more promising. In the future, this may be a possible key to overcoming the tendency for recurrence of deformity [ 52 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The use of genetically corrected autologous tissue engineered grafts looks even more promising. In the future, this may be a possible key to overcoming the tendency for recurrence of deformity [ 52 ].…”
Section: Resultsmentioning
confidence: 99%
“…A recent study described the use of full thickness skin graft at the level of the first commissure and palm of the hand, while dermal substitutes (Integra® or Matriderm®) were used to cover the remaining commissures, digits, and the rest of the hand, followed by a split thickness skin graft. Maintenance of function was greater than 3 years in 57% of cases, and greater than 5 years in 33% of cases [ 52 ].…”
Section: Resultsmentioning
confidence: 99%
“…DEB is associated with a genetic mutation of COL7A1 gene that encodes collagen type VII. (2) In turn, the sublamina densa layer of the basement membrane separates. (7) The estimated prevalence of DEB was reported to be 2-6 affected individuals per a million births and 1:1 male to female ratio.…”
Section: Discussionmentioning
confidence: 99%
“…[8][9][10] Skin substitutes-acellular dermal matrices in particular-are often used as postsurgical healing strategies to quicken the healing process and reduce scarring tissue. [11][12][13] These tumors impact patients' life in terms of both overall and disease-free survival: in fact, cSCCs tend to relapse easily and reduce patient life expectancy. 14,15 The most recent guidelines for diagnosis and treatment of cSCCs in EB patients are based on expert consensus, but more data need to be collected in this setting.…”
Section: Introductionmentioning
confidence: 99%
“…Surgical excision is the standard of care but can be complicated by both the difficulties in identifying the tumor margins and the impairment in the wound‐healing process 8–10 . Skin substitutes—acellular dermal matrices in particular—are often used as postsurgical healing strategies to quicken the healing process and reduce scarring tissue 11–13 . These tumors impact patients’ life in terms of both overall and disease‐free survival: in fact, cSCCs tend to relapse easily and reduce patient life expectancy 14,15 …”
Section: Introductionmentioning
confidence: 99%